Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.

Maahs DM, Ogden LG, Kretowski A, Snell-Bergeon JK, Kinney GL, Berl T, Rewers M.

Diabetes. 2007 Nov;56(11):2774-9. Epub 2007 Jul 27.

3.

Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes.

Yang YS, Peng CH, Lin CK, Wang CP, Huang CN.

Intern Med. 2007;46(12):801-6. Epub 2007 Jun 15.

4.

Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients.

Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, Miccoli R, Del Prato S, Penno G.

Clin Chem. 2007 Mar;53(3):480-8. Epub 2007 Jan 26.

5.

Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes.

Premaratne E, MacIsaac RJ, Finch S, Panagiotopoulos S, Ekinci E, Jerums G.

Diabetes Care. 2008 May;31(5):971-3. doi: 10.2337/dc07-1588. Epub 2008 Mar 4.

PMID:
18319326
6.

Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study.

Donahue RP, Stranges S, Rejman K, Rafalson LB, Dmochowski J, Trevisan M.

Diabetes Care. 2007 Jul;30(7):1724-9. Epub 2007 Apr 24.

PMID:
17456840
7.

[If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].

Peczyńska J, Urban M, Głowińska B, Florys B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):141-6. Polish.

PMID:
16232367
8.
9.

Comparative performance of serum cystatin-c versus serum creatinine in diabetic subjects.

Buysschaert M, Joudi I, Wallemacq P, Hermans MP.

Diabetes Metab. 2003 Sep;29(4 Pt 1):377-83.

PMID:
14526265
10.

Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.

Wadwa RP, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, Cornell E, Tracy RP, Rewers M.

Int J Biochem Cell Biol. 2006;38(5-6):996-1003. Epub 2005 Oct 18.

PMID:
16271309
11.

The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.

Lee BW, Ihm SH, Choi MG, Yoo HJ.

Diabetes Res Clin Pract. 2007 Dec;78(3):428-34. Epub 2007 Sep 5.

PMID:
17822797
12.

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.

Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.

Ren Fail. 2008;30(6):625-8. doi: 10.1080/08860220802134607.

PMID:
18661413
13.

[Cystatin C and adiponectin in diabetics with and without coronary artery disease].

Wolff C, Durruty P, Espinoza J, Ripamonti S, Díaz J.

Rev Med Chil. 2009 Jun;137(6):729-36. doi: /S0034-98872009000600001. Epub 2009 Sep 4. Spanish.

14.

Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes.

Kalansooriya A, Holbrook I, Jennings P, Whiting PH.

Br J Biomed Sci. 2007;64(3):121-3.

PMID:
17910281
15.

Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.

Ogawa Y, Goto T, Tamasawa N, Matsui J, Tando Y, Sugimoto K, Tomotsune K, Kimura M, Yasujima M, Suda T.

Diabetes Res Clin Pract. 2008 Feb;79(2):357-61. Epub 2007 Nov 5.

PMID:
17980929
16.

Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.

Mueller TF, Raeder J, Oettl K, Zitta S, Klausmann G, Estelberger W, Luyckx VA, Reibnegger G.

Ren Fail. 2008;30(1):21-9. doi: 10.1080/08860220701741916.

PMID:
18197539
17.
18.

Validation of predictive equations for glomerular filtration rate in the Saudi population.

Al Wakeel JS, Hammad D, Al Suwaida A, Tarif N, Chaudhary A, Isnani A, Albedaiwi WA, Mitwalli AH, Ahmad SS.

Saudi J Kidney Dis Transpl. 2009 Nov;20(6):1030-7.

19.

[Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer].

Bodnar L, Wcisło GB, elichowski G, Raczka A, Wańkowicz Z, Szczylik C.

Pol Merkur Lekarski. 2008 Apr;24(142):307-11. Polish.

PMID:
18634361
20.

Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.

Bostom AG, Bausserman L, Jacques PF, Liaugaudas G, Selhub J, Rosenberg IH.

Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2241-4.

Supplemental Content

Support Center